Auto-injectors are pre-filled, single-use, self-contained drug delivery systems that allow the user to self-administer precise dosages of injectable medication quickly and easily, without the ...

The Global Prefilled Auto Injectors Market is projected to grow at a CAGR of 8.4% from 2026 to 2033, according to a new report published by Verified Market Reports®. The report reveals that the market ...

TOKYO--(BUSINESS WIRE)--SHL, the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices, announced today that SHL Marketing Director Steven Kaufman will ...

Phillips-Medisize, in collaboration with its customer, Ascendis Pharma, was recently recognized with a third industry award for the Skytrofa Auto-Injector. The Red Dot Award recognizes the drug ...

My son Thomas has carried around a needle since he entered kindergarten at the age of 5. That was a big responsibility for a small child to carry an injector loaded with lifesaving epinephrine, but ...

- Supply agreement supports Viridian’s development of potential first- and best-in-class subcutaneous therapies for treatment of thyroid eye disease (TED) - - Ypsomed brings strong track record of ...

With training and planning, self-injecting your rheumatoid arthritis medication may be easier than you think.

Instron’s CT6 can be configured as an automated solution for the required testing of auto-injection devices – providing the benefits of automation without the additional complexity of a fully ...

Anaphylaxis is a serious, potentially life-threatening allergic reaction that can affect several organ systems in the body and may threaten breathing and blood circulation. The most common causes of ...

You might be able to give yourself shots of your medicine at home as part of your treatment for rheumatoid arthritis. Self-injections may be an option for you if your RA doctor (rheumatologist) ...

WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare ...